Health Catalyst (HCAT) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Core Insights - Health Catalyst (HCAT) is expected to report quarterly earnings of $0.05 per share, reflecting a year-over-year decline of 28.6% [1] - Revenue projections stand at $75.08 million, indicating a decrease of 1.7% compared to the same quarter last year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, suggesting analysts have reevaluated their initial estimates [1][2] Revenue Estimates - Analysts predict 'Revenue- Professional services' will reach $23.08 million, a decline of 16.7% from the prior-year quarter [4] - 'Revenue- Technology' is estimated at $52.00 million, showing a year-over-year increase of 6.9% [4] Profit Estimates - The average prediction for 'Adjusted Gross Profit- Professional Services' is $4.45 million, down from $4.72 million reported in the same quarter last year [5] - The consensus estimate for 'Adjusted Gross Profit- Technology' is $34.90 million, compared to $31.57 million reported in the same quarter last year [5] Stock Performance - Health Catalyst shares have increased by 7% over the past month, outperforming the Zacks S&P 500 composite, which rose by 1.3% [5] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to closely follow overall market performance in the near term [5]